Literature DB >> 9108050

Caveolin mRNA levels are up-regulated by free cholesterol and down-regulated by oxysterols in fibroblast monolayers.

C J Fielding1, A Bist, P E Fielding.   

Abstract

In confluent fibroblast monolayers, an increase in the selective uptake of free cholesterol (FC) from plasma low density lipoprotein (LDL) was accompanied by an increase in FC efflux. The rate of FC efflux was proportional to the FC content of the cell surface caveolae and to mRNA levels of caveolin, an FC-binding protein of caveolae. Inhibitors of LDL-FC internalization reduced the increase in caveolin mRNA levels and FC efflux. Oxysterols reduced caveolin mRNA levels, as well as transport of FC to the cell surface and FC efflux. DNA antisense to caveolin reduced caveolin mRNA and inhibited FC efflux. These data suggest that regulation of FC efflux can contribute to cellular FC homeostasis when LDL levels are modified over the physiological range, and they link this regulation to caveolin.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9108050      PMCID: PMC20513          DOI: 10.1073/pnas.94.8.3753

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  33 in total

1.  Sequence and expression of caveolin, a protein component of caveolae plasma membrane domains phosphorylated on tyrosine in Rous sarcoma virus-transformed fibroblasts.

Authors:  J R Glenney; D Soppet
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-01       Impact factor: 11.205

2.  The picomole determination of free and total cholesterol in cells in culture.

Authors:  J G Heider; R L Boyett
Journal:  J Lipid Res       Date:  1978-05       Impact factor: 5.922

3.  A detergent-free method for purifying caveolae membrane from tissue culture cells.

Authors:  E J Smart; Y S Ying; C Mineo; R G Anderson
Journal:  Proc Natl Acad Sci U S A       Date:  1995-10-24       Impact factor: 11.205

4.  Reduction of caveolin and caveolae in oncogenically transformed cells.

Authors:  A J Koleske; D Baltimore; M P Lisanti
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

5.  Side-chain structure is critical for the transport of sterols from lysosomes to cytoplasm.

Authors:  Y Sato; K Nishikawa; K Aikawa; K Mimura; K Murakami-Murofushi; H Arai; K Inoue
Journal:  Biochim Biophys Acta       Date:  1995-06-27

6.  Characterization of Chinese hamster ovary cells that are resistant to 3-beta-[2-(diethylamino)ethoxy]androst-5-en-17-one inhibition of low density lipoprotein-derived cholesterol metabolism.

Authors:  L Liscum; G J Collins
Journal:  J Biol Chem       Date:  1991-09-05       Impact factor: 5.157

7.  Plasma membrane caveolae mediate the efflux of cellular free cholesterol.

Authors:  P E Fielding; C J Fielding
Journal:  Biochemistry       Date:  1995-11-07       Impact factor: 3.162

8.  Oxysterols present in atherosclerotic tissue decrease the expression of lipoprotein lipase messenger RNA in human monocyte-derived macrophages.

Authors:  L M Hultén; H Lindmark; U Diczfalusy; I Björkhem; M Ottosson; Y Liu; G Bondjers; O Wiklund
Journal:  J Clin Invest       Date:  1996-01-15       Impact factor: 14.808

9.  Endothelial caveolae have the molecular transport machinery for vesicle budding, docking, and fusion including VAMP, NSF, SNAP, annexins, and GTPases.

Authors:  J E Schnitzer; J Liu; P Oh
Journal:  J Biol Chem       Date:  1995-06-16       Impact factor: 5.157

10.  VIP21, a 21-kD membrane protein is an integral component of trans-Golgi-network-derived transport vesicles.

Authors:  T V Kurzchalia; P Dupree; R G Parton; R Kellner; H Virta; M Lehnert; K Simons
Journal:  J Cell Biol       Date:  1992-09       Impact factor: 10.539

View more
  41 in total

Review 1.  Caveolins, liquid-ordered domains, and signal transduction.

Authors:  E J Smart; G A Graf; M A McNiven; W C Sessa; J A Engelman; P E Scherer; T Okamoto; M P Lisanti
Journal:  Mol Cell Biol       Date:  1999-11       Impact factor: 4.272

Review 2.  Caveolae: an alternative membrane transport compartment.

Authors:  M Gumbleton; A G Abulrob; L Campbell
Journal:  Pharm Res       Date:  2000-09       Impact factor: 4.200

3.  Oxidative stress inhibits caveolin-1 palmitoylation and trafficking in endothelial cells.

Authors:  Marie-Odile Parat; Rafal Z Stachowicz; Paul L Fox
Journal:  Biochem J       Date:  2002-02-01       Impact factor: 3.857

4.  Caveolae and lipid trafficking in adipocytes.

Authors:  Paul F Pilch; Tova Meshulam; Shiying Ding; Libin Liu
Journal:  Clin Lipidol       Date:  2011

5.  Two sterol regulatory element-like sequences mediate up-regulation of caveolin gene transcription in response to low density lipoprotein free cholesterol.

Authors:  A Bist; P E Fielding; C J Fielding
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-30       Impact factor: 11.205

6.  Caveolin-1 regulates osteoclastogenesis and bone metabolism in a sex-dependent manner.

Authors:  Yong Deok Lee; Soo-Hyun Yoon; Cheol Kyu Park; Jiyeon Lee; Zang Hee Lee; Hong-Hee Kim
Journal:  J Biol Chem       Date:  2015-01-05       Impact factor: 5.157

7.  Interaction with caveolin-1 modulates vascular ATP-sensitive potassium (KATP) channel activity.

Authors:  Lowri M Davies; Gregor I Purves; Richard Barrett-Jolley; Caroline Dart
Journal:  J Physiol       Date:  2010-07-12       Impact factor: 5.182

Review 8.  Caveolin-1 in oral squamous cell carcinoma microenvironment: an overview.

Authors:  Samapika Routray
Journal:  Tumour Biol       Date:  2014-08-16

Review 9.  Signaling epicenters: the role of caveolae and caveolins in volatile anesthetic induced cardiac protection.

Authors:  Yousuke T Horikawa; Yasuo M Tsutsumi; Hemal H Patel; David M Roth
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

10.  Caveolin-1 restoration by cholesterol enhances the inhibitory effect of simvastatin on arginine vasopressin-induced cardiac fibroblasts proliferation.

Authors:  Shaowei Liu; Yanping He; Yufeng Dou; Haichang Wang; Ling Tao; Lianyou Zhao; Fujun Shang; Hui Liu
Journal:  Mol Cell Biochem       Date:  2009-05-18       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.